Healthcare >> CEO Interviews >> April 27, 1999
PEGGY V. PHILLIPS is Senior Vice President of Pharmaceutical
Development, a member of the Immunex Board of Directors, and is
responsible for the development of compounds through product launch,
which includes Medical Development (Clinical, Professional Services,
Biometrics), Drug Development (Manufacturing, Quality, Regulatory &
Process Science) and Project Management. She is General Manager for
ENBREL (etanercept), which included development, the launch, and
currently, P&L. Ms. Phillips also serves as the co-Chair of the Enbrel
Management Committee, coordinating all sales and marketing activities
with Wyeth-Ayerst. Ms. Phillips has held senior management positions
within the research and development organization, including Senior Vice
President, Chief Operating Officer of Immunex Research and Development
Corporation. Previously, she held positions of increasing responsibility
at Miles Laboratories. Ms. Phillips received her M.S. Microbiology at
the University of Idaho. Board Positions held by Ms. Phillips are as
follows: 1994 to present-Board of Directors, Alliance for Education;
1997 to present- Executive Committee, Alliance for Education; 1998 -
Advisory Board, Middle School Science Systemic Change Partnership; 1998
to present -Board of Directors, American Society of Health-System
Pharmacists Research and Education Foundation. Profile
of Immunex just to set the stage for the readers?
Ms. Phillips: Immunex is located in Seattle, Washington and is 18
